311P Pooled-analysis of prospective observational studies evaluated the effectiveness and safety of bevacizumab and paclitaxel as the first-line chemotherapy for HER2-negative metastatic breast cancer
Yamashiro, H., Yamamoto, Y., Schneeweiss, A., Müller, V., Gluz, O., Klare, P., Aktas, B., Magdolna, D., Büdi, L., Pikó, B., Mangel, L., Toi, M., Morita, S., Ohno, S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
550PSAFETY AND EFFICACY OF PANITUMUMAB (PMAB) MONOTHERAPY IN RECURRENT OR PROGRESSIVE METASTATIC COLORECTAL CANCER (MCRC): RESULTS FROM A NON-INTERVENTIONAL STUDY (VECTIS)
Lakomy, R., Rogowski, W., Pikó, B., Mihaylova, Z., Pritzova, E., Kvocekova, L.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Safety and Efficacy of Panitumumab (Pmab) Monotherapy in Recurrent or Progressive Metastatic Colorectal Cancer (Mcrc): Results from a Non-Interventional Study (Vectis)
Lakomy, R., Rogowski, W., Pikó, B., Mihaylova, Z., Pritzova, E., Kvocekova, L.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Use Of Panitumumab in Patients with Recurrent or Progressive Colorectal Cancer - an Interim Analysis of the Vectis Study
Lakomy, R., Rogowski, W., Pikó, B., András, C., Molnar, E.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article